SLFN11 was not induced following treatment with IFNα in activated T cells and this is similar to observations from cancer cells where IFNα induced expression of most SLFNs but not SLFN11, suggesting an altered activation pathway for SLFN11. The gene discussed is IFNA2; the disease is cancer.